NIH issued a reminder that any renegotiated Aims, Objectives, Titles, or Abstracts—especially those aligned to NIH’s FY25 agency priorities—constitute a formal change in scope. Once agreed to by NIH and the institution’s AOR, these changes become new terms and conditions of award.
Key Impacts to Institutions (IHEs)
• AOR Accountability: Any approved scope change now carries the same compliance weight as other terms and conditions. Institutions must ensure internal review, documentation, and communication of any renegotiated scopes before accepting the modified award.
• Risk of Enforcement: Failure to follow revised scopes can trigger immediate enforcement actions under 2 CFR 200, including termination for non-compliance under §200.340. Terminations will be reported in SAM.gov, increasing institutional risk.
• Funds Drawdown = Acceptance: Once the institution draws funds, NIH considers the revised terms accepted. Institutions must ensure PIs understand and comply before drawdown.
• Increased Administrative Burden: Post-award offices will need heightened monitoring of Notice of Award changes, PI communication, and alignment with the newly negotiated scope.
Key Impacts to PIs
• Revised Aims Are Binding: Any renegotiated scientific direction becomes part of the award’s enforceable terms. PIs must strictly adhere to the updated scope.
• No Assumptions: PIs should not begin or continue work under revised scopes until they have explicit institutional and NIH confirmation.
• Clarification Required: NIH directs PIs/institutions to seek clarification from their Grants Management Official before drawing funds if there is any uncertainty about the revised terms.
• Non-Compliance Risk: Failure to follow updated scopes can result in termination of the award and loss of future funding eligibility.
Bottom Line
This notice elevates the compliance risk around NIH-negotiated changes to project aims and scope. Institutions must ensure strengthened internal controls for reviewing revised scopes, documenting PI understanding, and preventing drawdowns until all parties agree to the updated terms.
Read the NIH notice: NOT-OD-26-007
